Clinical trials
Phase 1/2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 8 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 3 |
| National Cancer Institute (NCI) | 3 |
| M.D. Anderson Cancer Center | 2 |
| Mayo Clinic | 2 |
| Northwestern University | 2 |
| Therapeutic Advances in Childhood Leukemia Consortium | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Atara Biotherapeutics | 1 |
| Cancer Treatment Centers of America | 1 |
| Cellestia Biotech AG | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 24 |
| Burkitt Lymphoma | 16 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 16 |
| Hodgkin Disease | 13 |
| Lymphoma, B-Cell, Marginal Zone | 13 |
| Lymphoma, Follicular | 13 |
| Lymphoma, Large B-Cell, Diffuse | 13 |
| Lymphoma, Mantle-Cell | 13 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 12 |
| Lymphoma, Large-Cell, Anaplastic | 12 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.